Noray BG

États‑Unis d’Amérique

Retour au propriétaire

1-28 de 28 pour Noray BG Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 23
        Marque 5
Juridiction
        International 10
        États-Unis 8
        Canada 6
        Europe 4
Date
2022 1
2021 2
Avant 2021 25
Classe IPC
A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar 7
A61K 8/73 - Polysaccharides 6
A61F 2/02 - Prothèses implantables dans le corps 5
A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées 5
A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada 5
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 5
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 4
10 - Appareils et instruments médicaux 2
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser. 1
35 - Publicité; Affaires commerciales 1
Statut
En Instance 1
Enregistré / En vigueur 27

1.

NEW ANTIOXIDANT COMPOSITION FOR WOUND HEALING

      
Numéro d'application 17629229
Statut En instance
Date de dépôt 2019-07-24
Date de la première publication 2022-10-06
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Herrero De Miguel, Jone
  • Castro Feo, Maria Begona
  • Bastida Corcuera, Felix Daniel

Abrégé

The present invention is comprised in the cosmetic and/or therapeutic industry and specifically relates to a new composition for topical use with antioxidant and hydrating activity which promotes wound healing and is useful in therapeutic and/or cosmetic treatment, as well as in the prevention of skin lesions. The present invention is comprised in the cosmetic and/or therapeutic industry and specifically relates to a new composition for topical use with antioxidant and hydrating activity which promotes wound healing and is useful in therapeutic and/or cosmetic treatment, as well as in the prevention of skin lesions. The novel composition object of the present invention incorporates certain agents and ingredients, among which are carotenoids and the galactomannans, which surprisingly improve the healing and curing activity in a broad spectrum of wounds occurring with the presence of reactive oxygen species.

Classes IPC  ?

  • A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada
  • A61K 31/01 - Hydrocarbures
  • A61K 31/122 - Cétones ayant l'atome d'oxygène lié directement à un cycle, p. ex. quinones, vitamine K1, anthraline
  • A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
  • A61K 31/015 - Hydrocarbures carbocycliques
  • A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar
  • A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
  • A61K 9/06 - OnguentsExcipients pour ceux-ci
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

2.

NEW ANTIOXIDANT COMPOSITION FOR WOUND HEALING

      
Numéro d'application ES2019070520
Numéro de publication 2021/014032
Statut Délivré - en vigueur
Date de dépôt 2019-07-24
Date de publication 2021-01-28
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Herrero De Miguel, Jone
  • Castro Feo, María Begoña
  • Bastida Corcuera, Felix Daniel

Abrégé

The present invention is intended for use in the cosmetic and/or therapeutic industry and specifically relates to a new composition for topical use with antioxidant and hydrating activity which promotes wound healing and is suitable for use in the therapeutic and/or cosmetic treatment, and also prevention, of skin lesions. The novel composition of the present invention incorporates certain agents and ingredients, including carotenoids and galactomannans, which dramatically improve the healing and curing activity across a broad spectrum of wounds associated with the presence of reactive oxygen species.

Classes IPC  ?

  • A61L 26/00 - Aspects chimiques des bandages liquides ou utilisation de matériaux pour les bandages liquides
  • A23L 5/44 - Adjonction de colorants ou de pigments, p. ex. en combinaison avec des azurants optiques en utilisant des colorants ou des pigments organiques d'origine naturelle, leurs doublons artificiels ou leurs dérivés en utilisant des caroténoïdes ou des xanthophylles
  • A61K 8/73 - Polysaccharides
  • A61K 31/01 - Hydrocarbures
  • A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar
  • A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada

3.

ANTIOXIDANT COMPOSITION FOR WOUND HEALING

      
Numéro de document 03143472
Statut Délivré - en vigueur
Date de dépôt 2019-07-24
Date de disponibilité au public 2021-01-28
Date d'octroi 2025-07-29
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Herrero De Miguel, Jone
  • Castro Feo, Maria Begona
  • Bastida Corcuera, Felix Daniel

Abrégé

The present invention is comprised in the cosmetic and/or therapeutic industry and specifically relates to a new composition for topical use with antioxidant and hydrating activity which promotes wound healing and is useful in therapeutic and/or cosmetic treatment, as well as in the prevention of skin lesions. The novel composition object of the present invention incorporates certain agents and ingredients, among which are carotenoids and the galactomannans, which surprisingly improve the healing and curing activity in a broad spectrum of wounds occurring with the presence of reactive oxygen species.

Classes IPC  ?

  • A23L 5/44 - Adjonction de colorants ou de pigments, p. ex. en combinaison avec des azurants optiques en utilisant des colorants ou des pigments organiques d'origine naturelle, leurs doublons artificiels ou leurs dérivés en utilisant des caroténoïdes ou des xanthophylles
  • A61K 8/73 - Polysaccharides
  • A61K 31/01 - Hydrocarbures
  • A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar
  • A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada
  • A61L 26/00 - Aspects chimiques des bandages liquides ou utilisation de matériaux pour les bandages liquides

4.

HISTOESSENCE

      
Numéro d'application 017938696
Statut Enregistrée
Date de dépôt 2018-08-02
Date d'enregistrement 2018-12-05
Propriétaire HISTOCELL, S.L. (Espagne)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Pharmaceutical preparations for medical and veterinary use; Sanitary preparations for medical purposes; Chemico-pharmaceutical preparations; Skin care preparations for medical use; Pharmaceutical preparations for skin care; Antimicrobials for dermatologic use; Stem cells for medical purposes; Stem cells for veterinary purposes; Cultures for medical use; Cultures for veterinary use; Cellular function activating agents for medical purposes; Surgical implants grown from stem cells; Transplants [living tissues]; Bandages for skin wounds; Pharmaceutical agents for treating physically caused lesions; Surgical plasters; Materials for dressings; Homeopathic pharmaceuticals; Dietetic food and substances adapted for medical or veterinary use, food for babies; Food supplements for human beings and animals; Mineral food supplements; Material for stopping teeth, dental wax; Teeth filling material; Dietary supplements with a cosmetic effect; Disinfectants; Preparations for destroying vermin; Herbicides; Fungicides. Medical services; Medical services; Medical services in the field of treatment of chronic pain; Advisory services relating to degenerative diseases; Providing medical advice in the field of dermatology; Dermatological services for treating skin conditions; Consultancy services relating to cosmetics; Psychological counseling; Psychiatric services; Performing diagnosis of diseases; Medical testing services relating to the diagnosis and treatment of disease; Alternative medicine services; Stem cell storage; Medical services relating to the removal, treatment and processing of stem cells; Medical services relating to the removal, treatment and processing of bone marrow; Analysis of human tissues for medical treatment; Cosmetic treatment; Veterinary services; Human hygiene and beauty care; Hygienic and beauty care for animals; Development of individual physical rehabilitation programmes; Advice relating to the personal welfare of elderly people [health]; Agriculture, horticulture and forestry services; Providing information about agriculture, horticulture, and forestry services; Medical equipment rental.

5.

NEUROSAVE

      
Numéro d'application 017907304
Statut Enregistrée
Date de dépôt 2018-05-28
Date d'enregistrement 2018-11-17
Propriétaire HISTOCELL, S.L. (Espagne)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Pharmaceutical preparations for medical and veterinary use; Sanitary preparations for medical purposes; Pharmaceutical preparations; Chemico-pharmaceutical preparations; Stem cells for medical purposes; Stem cells for veterinary purposes; Cultures for medical use; Cultures for veterinary use; Cellular function activating agents for medical purposes; Surgical implants grown from stem cells; Transplants [living tissues]; Pharmaceutical agents for treating physically caused lesions; Homeopathic pharmaceuticals; Mineral food supplements; plasters; Materials for dressings; Material for stopping teeth, dental wax; Disinfectants; Herbicides; Fungicides. Medical services; Medical services; Medical services in the field of treatment of chronic pain; Advisory services relating to degenerative diseases; Psychological counseling; Psychiatric services; Performing diagnosis of diseases; Medical testing services relating to the diagnosis and treatment of disease; Alternative medicine services; Stem cell storage; Medical services relating to the removal, treatment and processing of stem cells; Medical services relating to the removal, treatment and processing of bone marrow; Analysis of human tissues for medical treatment; Cosmetic treatment; Veterinary services; Development of individual physical rehabilitation programmes; Advice relating to the personal welfare of elderly people [health]; Medical equipment rental.

6.

Biomaterial scaffold for regenerating the oral mucosa

      
Numéro d'application 15520986
Numéro de brevet 11241516
Statut Délivré - en vigueur
Date de dépôt 2015-10-23
Date de la première publication 2017-11-30
Date d'octroi 2022-02-08
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Castro Feo, María Begoña
  • Baiget Orts, Amparo

Abrégé

The present invention refers to a process for preparing a biomaterial scaffold said method comprising, (a) providing a hydrogel comprising a fibrin network and a polysaccharide network; (b) subjecting the hydrogel of step a) to a freeze-thawing process to physically crosslink the hydrogel; and (c) subjecting the physically cross-linked hydrogel obtained after conducting the step b), to a lyophilization. The invention also relates to the biomaterial scaffold obtainable by the process as defined above, as well said biomaterial scaffold for its use to partially or completely increase, restore or replace the functional activity of a diseased or damaged oral mucosa.

Classes IPC  ?

7.

Antioxidant composition

      
Numéro d'application 15283759
Numéro de brevet 10231992
Statut Délivré - en vigueur
Date de dépôt 2016-10-03
Date de la première publication 2017-01-26
Date d'octroi 2019-03-19
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Castro Feo, María Begoña
  • Azcoitia Ramsden, Iker
  • Palomares Casado, Teodoro
  • Herrero De Miguel, Jone
  • Alonso Varona, Ana Isabel
  • Del Olmo Basterrechea, Maite

Abrégé

The present invention relates to an antioxidant composition comprising a combination of galatomannan and N-acetyl cysteine for its use in the treatment of a skin disease or condition resulting from reactive oxygen species production in the skin or involving reactive oxygen species production in the skin, to a hydrogel containing said combination as well as to dressing wounds comprising said hydrogel and its use in the healing of ulcers, wounds, burns and scalds.

Classes IPC  ?

  • A61K 8/00 - Cosmétiques ou préparations similaires pour la toilette
  • A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar
  • A61K 31/12 - Cétones
  • A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
  • A61K 36/483 - Gleditsia (caroube)
  • A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada
  • A61K 35/33 - Fibroblastes
  • A61K 8/73 - Polysaccharides
  • A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
  • A61K 35/30 - NerfsCerveauYeuxCellules cornéennesLiquide céphalorachidienCellules souches neuronalesCellules précurseurs neuronalesCellules glialesOligodendrocytesCellules de SchwannAstrogliesAstrocytesPlexus choroïdeTissu de moelle épinière
  • A61K 35/32 - OsOstéocytesOstéoblastesTendonsTénocytesDentsOdontoblastesCartilageChondrocytesMembrane synoviale
  • A61K 35/36 - PeauSystème pileuxOnglesGlandes sébacéesCérumenÉpidermeCellules épithélialesKératinocytesCellules de LangerhansCellules ectodermiques
  • A61Q 19/00 - Préparations pour les soins de la peau
  • A61K 8/35 - Cétones, p. ex. quinones, benzophénone
  • A61K 8/44 - Acides aminocarboxyliques ou leurs dérivés, p. ex. acides aminocarboxyliques contenant du soufreLeurs sels, esters ou dérivés N-acylés
  • A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
  • A61Q 19/08 - Préparations contre le vieillissement
  • A61K 8/04 - DispersionsÉmulsions
  • A61K 8/46 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant du soufre
  • A61K 8/98 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés d'origine animale
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

8.

A BIOMATERIAL SCAFFOLD FOR REGENERATING THE ORAL MUCOSA

      
Numéro de document 02964501
Statut Délivré - en vigueur
Date de dépôt 2015-10-23
Date de disponibilité au public 2016-04-28
Date d'octroi 2023-05-16
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Castro Feo, Begona
  • Baiget Orts, Amparo

Abrégé

The present invention refers to a process for preparing a biomaterial scaffold said method comprising, (a) providing a hydrogel comprising a fibrin network and a polysaccharide network; (b) subjecting the hydrogel of step a) to a freeze-thawing process to physically crosslink the hydrogel; and (c) subjecting the physically cross-linked hydrogel obtained after conducting the step b), to a lyophilization. The invention also relates to the biomaterial scaffold obtainable by the process as defined above, as well said biomaterial scaffold for its use to partially or completely increase, restore or replace the functional activity of a diseased or damaged oral mucosa.

Classes IPC  ?

  • A61L 27/26 - Mélanges de matériaux macromoléculaires
  • A61L 27/56 - Matériaux poreux ou cellulaires

9.

A BIOMATERIAL SCAFFOLD FOR REGENERATING THE ORAL MUCOSA

      
Numéro d'application EP2015074610
Numéro de publication 2016/062862
Statut Délivré - en vigueur
Date de dépôt 2015-10-23
Date de publication 2016-04-28
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Castro Feo, Begoña
  • Baiget Orts, Amparo

Abrégé

The present invention refers to a process for preparing a biomaterial scaffold said method comprising, (a) providing a hydrogel comprising a fibrin network and a polysaccharide network; (b) subjecting the hydrogel of step a) to a freeze-thawing process to physically crosslink the hydrogel; and (c) subjecting the physically cross-linked hydrogel obtained after conducting the step b), to a lyophilization. The invention also relates to the biomaterial scaffold obtainable by the process as defined above, as well said biomaterial scaffold for its use to partially or completely increase, restore or replace the functional activity of a diseased or damaged oral mucosa.

Classes IPC  ?

  • A61L 27/26 - Mélanges de matériaux macromoléculaires
  • A61L 27/56 - Matériaux poreux ou cellulaires

10.

Reoxcare

      
Numéro d'application 1271121
Statut Enregistrée
Date de dépôt 2015-07-30
Date d'enregistrement 2015-07-30
Propriétaire HISTOCELL, S.L. (Espagne)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Pharmaceutical and veterinary products; medicinal oils; amino acids for medical purposes, amino acids for veterinary purposes; diagnostic products for medical use; bacteriological culture media; bacteriological preparations for medical or veterinary use; implantable materials for use in guided tissue regeneration, regenerative tissue [pharmaceutical preparations]; sanitary preparations for medical purposes, medicines for dental purposes; medical dressings, items for dressings; therapeutic creams [medicated]; organotherapy preparations, opotherapy products; dietetic substances for medical use, food for babies; edible non-nutritive plant fibers; nutritional additives for medical purposes, mineral food supplements; preparations of microorganisms for medical and veterinary use; fish meal for pharmaceutical purposes; fungicides, herbicides, products for destroying vermin. Surgical, medical, dental and veterinary apparatus and instruments, as well as artificial limbs, eyes and teeth; orthopedic articles; suture materials; diagnostic apparatus for medical purposes, detection instruments for veterinary use, veterinary diagnostic tools; lasers for medical purposes, lasers with veterinary purposes; supportive bandages. Medical services, psychology services, telemedicine services, health services, dentistry, therapeutic services; veterinary services; surgery; medical analyses; analysis of human tissues for medical treatment; animal breeding; updating of personal medical records registers and archives; rental of medical equipment; cosmetic surgery, aesthetic surgery; cosmetic treatment, cosmetic consultancy, beautician services; hygiene and beauty care for humans or animals; development of individual physical rehabilitation programs; rehabilitation for substance abuse patients; advice concerning personal well-being in the elderly [health]; preparation and dispensing of medicines; providing home health care services; providing mental rehabilitation facilities; nursing homes; elimination of vermin for agriculture, horticulture and forestry.

11.

Reoxcare

      
Numéro d'application 013287651
Statut Enregistrée
Date de dépôt 2014-09-22
Date d'enregistrement 2015-02-12
Propriétaire HISTOCELL, S.L. (Espagne)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Pharmaceutical and veterinary preparations; Medicinal oils; Amino acids for medical purposes, amino acids for veterinary purposes; Diagnostic preparations; Mediums (Bacteriological culture -); Bacteriological preparations for medical and veterinary use; Implantable materials for use in guided tissue regeneration, Regenerative tissue (pharmaceutical preparations); Sanitary preparations for medical purposes, Medicines for dental purposes; Dressings, medical, Dressings, medical; Therapeutic creams [medical]; Organotherapy preparations, Organotherapy preparations; Dietetic substances adapted for medical use, food for babies; Edible, non-nutritive plant fibres; Nutritional additives for medical purposes, mineral food-supplements; Cultures of microorganisms for medical and veterinary use; Fish meal for pharmaceutical purposes; Fungicides, Herbicides, Preparations for destroying vermin. Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; Orthopedic articles; Suture materials; Diagnostic apparatus for medical purposes, Detecting instruments for veterinary use, Tools for veterinary diagnostics; Lasers for medical purposes, Lasers for veterinary purposes; Bandages for joints, anatomical. Medical services, Psychologist (Services of a -), Telemedicine services, Human healthcare services, Dentistry, Therapy services; Veterinary services; Surgery; Medical screening; Analysis of human tissues for medical treatment; Farming (animals); Maintaining personal medical history records and files; Medical equipment rental; Surgery (Cosmetic -), Plastic surgery; Cosmetic treatment, Consultancy services relating to cosmetics, Beauty salons; Hygiene and beauty care for people or animals; Development of individual physical rehabilitation programmes; Rehabilitation for substance abuse patients; Advice relating to the personal welfare of elderly people [health]; Preparation and dispensing of medications; Provision of health care services in domestic homes; Providing mental rehabilitation facilities; Nursing homes; Vermin exterminating for agriculture, horticulture and forestry.

12.

Treatment method for mesenchymal stem cells and their application as a treatment of oxidative stress related diseases

      
Numéro d'application 14131049
Numéro de brevet 09080153
Statut Délivré - en vigueur
Date de dépôt 2011-07-06
Date de la première publication 2014-06-05
Date d'octroi 2015-07-14
Propriétaire HISTOCELL S.L. (Espagne)
Inventeur(s)
  • Castro, Maria Begona
  • Diez Garcia, Javier

Abrégé

The present invention relates to a method of treatment of mesenchymal stem cells, preferably from adipose origin, comprising mainly two stages, firstly the collection and isolation of mesenchymal stem cells, and secondly, a period of growth and specific treatment of cells in a conditioning or treatment medium with an oxidizing agent. The invention also comprises the cells obtained directly through the method and its use in treating diseases caused by or associated with oxidative stress.

Classes IPC  ?

  • A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
  • C12N 5/0775 - Cellules souches mésenchymateusesCellules souches dérivées du tissu adipeux
  • A61K 35/28 - Moelle osseuseCellules souches hématopoïétiquesCellules souches mésenchymateuses de toutes origines, p. ex. cellules souches dérivées de tissu adipeux

13.

Wharton Gel Complex

      
Numéro d'application 012065314
Statut Enregistrée
Date de dépôt 2013-08-14
Date d'enregistrement 2014-01-08
Propriétaire HISTOCELL, S.L. (Espagne)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 35 - Publicité; Affaires commerciales

Produits et services

Oils for toilet purposes, oils for cosmetic purposes; Soaps; Perfumery products, Ethereal oils, Cosmetics, Cosmetic creams, Cosmetic dyes, Hair lotions; Tissues impregnated with cosmetic lotions, Adhesives for cosmetic purposes. Pharmaceutical and veterinary preparations; Sanitary preparations for medical purposes; Dietetic food and substances adapted for medical or veterinary use, food for babies; Dietary supplements for humans and animals; Plasters, materials for dressings; Material for stopping teeth, dental wax; Disinfectants; Preparations for destroying vermin; Fungicides, herbicides; Diagnostic preparations for medical purposes; Bacterial and bacteriological preparations for medical or veterinary purposes; Implantable materials for use in guided tissue regeneration, Regenerative tissue (pharmaceutical preparations); Disinfectant dressings, Wound dressing; Medicinal creams for protection of the skin, Therapeutic creams (medicated); Organ therapeutic preparations, Opotherapy preparations; Immunotherapeutic agents for bacterial infections; Cultures of micro-organisms for medical and veterinary use. Sales promotion for others; Business representative services; Presentation of goods on communication media, for retail purposes; Retailing of cosmetics and perfumery, dietary supplements, food and vitamin preparations for the pharmaceutical and healthcare sector, pharmaceutical and veterinary preparations, dressings and bandages, regenerative tissue, bacteriological preparations, sanitary preparations for medical and veterinary purposes, parapharmaceuticals, disinfectants, fungicides and herbicides, medical and veterinary apparatus and instruments, apparatus and instruments for therapeutic and diagnostic purposes; Business management assistance; Outsourcing services (business assistance); Advertising; Commercial administration of the licensing of the goods and services of others; Business consultancy relating to franchising; Organisation of trade fairs and exhibitions for commercial and advertising purposes.

14.

Biomaterial from Wharton's jelly umbilical cord

      
Numéro d'application 13638535
Numéro de brevet 10226480
Statut Délivré - en vigueur
Date de dépôt 2010-03-30
Date de la première publication 2013-04-18
Date d'octroi 2019-03-12
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Font Perez, Julio
  • Castro Feo, Maria Begoña
  • Del Olmo Basterrechea, Maite

Abrégé

The present invention relates to a biomaterial, specifically a hydrogel, based on the extracellular matrix of the umbilical cord for its application in regenerative medicine. The invention particularly relates to a biomaterial made up of glycosaminoglycans present exclusively in the Wharton's jelly of the umbilical cord (which can optionally be combined with cells as a combination therapy), and also to the methods for the production and use thereof.

Classes IPC  ?

  • A61K 31/726 - Glycosaminoglycanes, c.-à-d. mucopolysaccharides
  • A61K 8/04 - DispersionsÉmulsions
  • A61K 8/98 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés d'origine animale
  • A61L 27/26 - Mélanges de matériaux macromoléculaires
  • A61L 27/56 - Matériaux poreux ou cellulaires
  • A61L 27/52 - Hydrogels ou hydrocolloïdes
  • A61K 35/30 - NerfsCerveauYeuxCellules cornéennesLiquide céphalorachidienCellules souches neuronalesCellules précurseurs neuronalesCellules glialesOligodendrocytesCellules de SchwannAstrogliesAstrocytesPlexus choroïdeTissu de moelle épinière
  • A61K 35/14 - SangSang artificiel
  • A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
  • A61K 31/727 - HéparineHéparane
  • A61Q 19/08 - Préparations contre le vieillissement
  • A61K 8/73 - Polysaccharides
  • A61K 35/44 - VaisseauxCellules de muscles vasculaires lissesCellules endothélialesCellules progénitrices endothéliales
  • A61K 35/36 - PeauSystème pileuxOnglesGlandes sébacéesCérumenÉpidermeCellules épithélialesKératinocytesCellules de LangerhansCellules ectodermiques
  • A61K 35/35 - Tissu graisseuxAdipocytesCellules stromalesTissus conjonctifs
  • A61K 35/34 - MusclesCellules musculaires lissesCœurCellules souches cardiaquesMyoblastesMyocytesCardiomyocytes
  • A61K 35/33 - Fibroblastes
  • A61K 35/32 - OsOstéocytesOstéoblastesTendonsTénocytesDentsOdontoblastesCartilageChondrocytesMembrane synoviale
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/06 - OnguentsExcipients pour ceux-ci
  • A61K 31/737 - Polysaccharides sulfatés, p. ex. sulfate de chondroïtine, sulfate de dermatane
  • A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
  • A61K 31/728 - Acide hyaluronique
  • A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur

15.

Antioxidant composition

      
Numéro d'application 13704207
Numéro de brevet 09492475
Statut Délivré - en vigueur
Date de dépôt 2011-06-14
Date de la première publication 2013-04-18
Date d'octroi 2016-11-15
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Castro Feo, Maria Begoña
  • Azcoitia Ramsden, Iker
  • Palomares Casado, Teodoro
  • Herrero De Miguel, Jone
  • Alonso Varona, Ana Isabel
  • Del Olmo Basterrechea, Maite

Abrégé

The present invention relates to an antioxidant composition comprising a combination of galatomannan and N-acetyl cysteine for its use in the treatment of a skin disease or condition resulting from reactive oxygen species production in the skin or involving reactive oxygen species production in the skin, to a hydrogel containing said combination as well as to dressing wounds comprising said hydrogel and its use in the healing of ulcers, wounds, burns and scalds.

Classes IPC  ?

  • A61K 8/00 - Cosmétiques ou préparations similaires pour la toilette
  • A61K 8/18 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition
  • A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
  • A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar
  • A61K 31/12 - Cétones
  • A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
  • A61K 36/483 - Gleditsia (caroube)
  • A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada
  • A61K 35/33 - Fibroblastes
  • A61K 8/73 - Polysaccharides
  • A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
  • A61K 35/30 - NerfsCerveauYeuxCellules cornéennesLiquide céphalorachidienCellules souches neuronalesCellules précurseurs neuronalesCellules glialesOligodendrocytesCellules de SchwannAstrogliesAstrocytesPlexus choroïdeTissu de moelle épinière
  • A61K 35/32 - OsOstéocytesOstéoblastesTendonsTénocytesDentsOdontoblastesCartilageChondrocytesMembrane synoviale
  • A61K 35/36 - PeauSystème pileuxOnglesGlandes sébacéesCérumenÉpidermeCellules épithélialesKératinocytesCellules de LangerhansCellules ectodermiques
  • A61Q 19/00 - Préparations pour les soins de la peau

16.

A TREATMENT METHOD FOR MESENCHYMAL STEM CELLS AND THEIR APPLICATION AS A TREATMENT OF OXIDATIVE STRESS RELATED DISEASES

      
Numéro de document 02839106
Statut Délivré - en vigueur
Date de dépôt 2011-07-06
Date de disponibilité au public 2013-01-10
Date d'octroi 2018-01-02
Propriétaire HISTOCELL S.L. (Espagne)
Inventeur(s)
  • Castro, Maria Begona
  • Diez Garcia, Javier

Abrégé


The present invention relates to a method of treatment of mesenchymal stem
cells,
preferably from adipose origin, comprising mainly two stages, firstly the
collection and
isolation of mesenchymal stem cells, and secondly, a period of growth and
specific
treatment of cells in a conditioning or treatment medium with an oxidizing
agent. The
invention also comprises the cells obtained directly through the method and
its use in
treating diseases caused by or associated with oxidative stress.

Classes IPC  ?

  • C11D 3/39 - Percomposés organiques ou inorganiques
  • C12N 5/0775 - Cellules souches mésenchymateusesCellules souches dérivées du tissu adipeux

17.

METHOD FOR PROCESSING MESENCHYMAL STEM CELLS AND THE USE THEREOF IN THE TREATMENT OF DISEASES ASSOCIATED WITH OXIDATIVE STRESS

      
Numéro d'application ES2011070489
Numéro de publication 2013/004859
Statut Délivré - en vigueur
Date de dépôt 2011-07-06
Date de publication 2013-01-10
Propriétaire HISTOCELL S.L. (Espagne)
Inventeur(s)
  • Castro, María Begoña
  • Díez García, Javier

Abrégé

The present invention relates, first, to a method for processing mesenchymal stem cells, preferably of adipose origin, which basically comprises two steps, namely the production and isolation of mesenchymal cells, and, second, a step of growth and specific processing of the cells in a conditioning or processing medium with an oxidizing agent. The invention also comprises the cells obtained directly by means of the method and the use of said cells in the treatment of diseases caused by or associated with oxidative stress.

Classes IPC  ?

  • C12N 5/0775 - Cellules souches mésenchymateusesCellules souches dérivées du tissu adipeux
  • C11D 3/39 - Percomposés organiques ou inorganiques

18.

ANTIOXIDANT COMPOSITION

      
Numéro d'application ES2011070427
Numéro de publication 2011/157880
Statut Délivré - en vigueur
Date de dépôt 2011-06-14
Date de publication 2011-12-22
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Castro Feo, María Begoña
  • Azcoitia Ramsden, Iker
  • Palomares Casado, Teodoro
  • Herrero De Miguel, Jone
  • Alonso Varona, Ana Isabel
  • Del Olmo Basterrechea, Maite

Abrégé

The present invention relates to an antioxidant composition that comprises a combination of galactomannan and N-acetylcysteine for use in the treatment of a skin disease or condition that is the result of the production of reactive oxygen species in the skin or that involves the production of reactive oxygen species in the skin. The invention also relates to a hydrogel containing said combination, to wound dressings that comprise said hydrogel, and to the use thereof in the healing of ulcers, wounds, burns and scalds.

Classes IPC  ?

  • A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar
  • A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
  • A61K 31/12 - Cétones
  • A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
  • A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
  • A61P 17/16 - Émollients ou protecteurs, p. ex. contre les radiations
  • A61P 17/06 - Antipsoriasiques

19.

ANTIOXIDANT COMPOSITION COMPRISING GALACTOMANNAN AND N-ACETYL CYSTEINE

      
Numéro de document 02801048
Statut Délivré - en vigueur
Date de dépôt 2011-06-14
Date de disponibilité au public 2011-12-22
Date d'octroi 2018-06-12
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Castro Feo, Maria Begona
  • Azcoitia Ramsden, Iker
  • Palomares Casado, Teodoro
  • Herrero De Miguel, Jone
  • Alonso Varona, Ana Isabel
  • Del Olmo Basterrechea, Maite

Abrégé

The present invention relates to an antioxidant composition comprising a combination of galatomannan and N-acetyl cysteine for its use in the treatment of a skin disease or condition resulting from reactive oxygen species production in the skin or involving reactive oxygen species production in the skin, to a hydrogel containing said combination as well as to dressing wounds comprising said hydrogel and its use in the healing of ulcers, wounds, burns and scalds.

Classes IPC  ?

  • A61K 8/73 - Polysaccharides
  • A61K 31/12 - Cétones
  • A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
  • A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar
  • A61L 15/28 - Polysaccharides ou leurs dérivés
  • A61L 15/44 - Médicaments
  • A61L 15/60 - Matériaux gonflant avec les liquides pour former un gel, p. ex. super-absorbants
  • A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
  • A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
  • A61P 17/16 - Émollients ou protecteurs, p. ex. contre les radiations
  • A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer

20.

Biomaterial based on Wharton's jelly from the human umbilical cord

      
Numéro d'application 13123186
Numéro de brevet 08685732
Statut Délivré - en vigueur
Date de dépôt 2008-10-10
Date de la première publication 2011-10-20
Date d'octroi 2014-04-01
Propriétaire Histocell, S.L. (Espagne)
Inventeur(s)
  • Font Perez, Julio
  • Basterrechea, Maite Del Olmo
  • Castro Feo, Maria Begona
  • Infante Martinez, Arantza
  • Alonso Varona, Ana Isabel
  • Palomares Casado, Teodoro

Abrégé

The present invention relates to a biomaterial, specifically a hydrogel, formed from the extracellular matrix of the umbilical cord for its application in regenerative medicine. The invention particularly relates to a biomaterial made up of glycosaminoglycans isolated exclusively from the Wharton's jelly of the umbilical cord which can optionally contain cells, and also to the methods for the production and use thereof.

Classes IPC  ?

  • C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
  • C12N 5/02 - Propagation de cellules individuelles ou de cellules en suspensionLeur conservationMilieux de culture à cet effet
  • A61F 2/02 - Prothèses implantables dans le corps

21.

NEW BIOMATERIAL FROM WHARTON'S JELLY UMBILICAL CORD

      
Numéro de document 02794315
Statut Délivré - en vigueur
Date de dépôt 2010-03-30
Date de disponibilité au public 2011-10-06
Date d'octroi 2016-09-13
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Font Perez, Julio
  • Castro Feo, Maria Begona
  • Del Olmo Basterrechea, Maite

Abrégé

The present invention relates to a biomaterial, specifically a hydrogel, based on the extracellular matrix of the umbilical cord for its application in regenerative medicine. The invention particularly relates to a biomaterial made up of glycosaminoglycans present exclusively in the Wharton' s jelly of the umbilical cord (which can optionally be combined with cells as a combination therapy), and also to the methods for the production and use thereof.

Classes IPC  ?

  • A61K 31/726 - Glycosaminoglycanes, c.-à-d. mucopolysaccharides

22.

NEW BIOMATERIAL FROM WHARTON'S JELLY UMBILICAL CORD

      
Numéro d'application EP2010002011
Numéro de publication 2011/120535
Statut Délivré - en vigueur
Date de dépôt 2010-03-30
Date de publication 2011-10-06
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Font Perez, Julio
  • Castro Feo, Maria Begoña
  • Del Olmo Basterrechea, Maite

Abrégé

The present invention relates to a biomaterial, specifically a hydrogel, based on the extracellular matrix of the umbilical cord for its application in regenerative medicine. The invention particularly relates to a biomaterial made up of glycosaminoglycans present exclusively in the Wharton' s jelly of the umbilical cord (which can optionally be combined with cells as a combination therapy), and also to the methods for the production and use thereof.

Classes IPC  ?

  • A61K 31/726 - Glycosaminoglycanes, c.-à-d. mucopolysaccharides

23.

Three-dimensional matrices of structured porous monetite for tissue engineering and bone regeneration, and method of the preparation thereof

      
Numéro d'application 13002939
Numéro de brevet 09320828
Statut Délivré - en vigueur
Date de dépôt 2009-07-08
Date de la première publication 2011-06-30
Date d'octroi 2016-04-26
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Font Pérez, Julio
  • Castro Feo, Maria Begoña
  • Del Olmo Basterrechea, Maite
  • García Vázquez, Maria Dolores
  • Rubio Retama, Jorge
  • López Cabarcos, Enrique
  • Rueda Rodríguez, Carmen
  • Tamimi Mariño, Faleh
  • Hamdan Ali Alkhraisat, Mohammad

Abrégé

The present invention is comprised within tissue engineering and, specifically, within bone regeneration. The invention relates to a porous three-dimensional matrix of monetite which is biocompatible, has structured porosity and is predefined and reabsorbable, as well as to the method of synthesis capable of producing said material and the applications thereof. These matrices are a perfect base for cell colonization and proliferation, allowing the application thereof in tissue engineering and bone regeneration as a result of their advantageous properties of biocompatibility, reabsorption, osteoinduction, revascularization, etc.

Classes IPC  ?

  • A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
  • A61L 27/12 - Matériaux contenant du phosphore, p. ex. apatite
  • A61L 27/38 - Cellules animales
  • A61L 27/56 - Matériaux poreux ou cellulaires
  • A61L 27/58 - Matériaux au moins partiellement résorbables par le corps
  • C01B 25/32 - Phosphates de magnésium, de calcium, de strontium ou de baryum
  • A61F 2/28 - Os

24.

CELL TRANSPORT SYSTEM

      
Numéro d'application EP2009009132
Numéro de publication 2010/069589
Statut Délivré - en vigueur
Date de dépôt 2009-12-18
Date de publication 2010-06-24
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Gartzia Aranaga, Miren Itxaso
  • Del Olmo Basterrechea, Maite
  • Castro Feo, María Begoña
  • Acilu Pérez, Marta

Abrégé

The present invention relates to a system for cell transport Said system allows the transport of cells, assuring their integrity and viability during the entire transport process. It consists of a system suitable for a wide variety of formats which allows a broad range of technical applications of the system The system of the invention allows providing ready-to-use cells, without the cells having to be manipulated before they are used by technical experts in cell biology The invention particularly relates to an agarose plus agarase mixture covering or enveloping, depending on the format of the selected transport system, the cell culture, protecting it during the transport process, as well as to the methodology of cell recovery of the cells transported in the system.

Classes IPC  ?

  • A01N 1/02 - Conservation de parties vivantes
  • C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet

25.

NEW BIOMATERIAL BASED ON WHARTON'S JELLY FROM THE HUMAN UMBILICAL CORD

      
Numéro d'application ES2008000640
Numéro de publication 2010/040865
Statut Délivré - en vigueur
Date de dépôt 2008-10-10
Date de publication 2010-04-15
Propriétaire HISTOCELL S.L. (Espagne)
Inventeur(s)
  • Font Perez, Julio
  • Del Olmo Basterrechea, Maite
  • Castro Feo, Maria, Begoña
  • Infante Martinez, Arantza
  • Alonso Varona, Ana, Isabel
  • Palomares Casado, Teodoro

Abrégé

The invention relates to a biomaterial, specifically a hydrogel, made from the extracellular matrix of the umbilical cord for use in Regenerative Medicine. In particular, the invention relates to a biomaterial made up of glycosaminoglycans isolated exclusively from the Wharton's jelly of the umbilical cord, which biomaterial may optionally contain cells, and also to methods for the production and use thereof.

Classes IPC  ?

  • A61F 2/02 - Prothèses implantables dans le corps
  • C08L 5/08 - ChitineSulfate de chondroïtineAcide hyaluroniqueLeurs dérivés
  • C08L 5/10 - HéparineSes dérivés
  • A61L 27/44 - Matériaux composites, c.-à-d. en couches ou contenant un matériau dispersé dans une matrice constituée d'un matériau analogue ou différent comportant une matrice macromoléculaire
  • A61L 27/52 - Hydrogels ou hydrocolloïdes

26.

THREE-DIMENSIONAL MATRICES OF STRUCTURED POROUS MONETITE FOR TISSUE ENGINEERING AND OSSEOUS REGENERATION, AND METHOD FOR THE PREPARATION THEREOF

      
Numéro d'application ES2009000358
Numéro de publication 2010/004066
Statut Délivré - en vigueur
Date de dépôt 2009-07-08
Date de publication 2010-01-14
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Font Pérez, Julio
  • Castro Feo, María Begoña
  • Del Olmo Basterrechea, Mailte
  • García Vázquez, María Dolores
  • Rubio Retama, Jorge
  • López Cabarcos, Enrique
  • Rueda Rodríguez, Carmen
  • Tamimi Mariño, Faleh
  • Hamdan Ali Alkhraisat, Mohammad

Abrégé

The present invention is in the field of tissue engineering and, specifically, that of osseous regeneration. The invention relates to a porous three-dimensional matrix of biocompatible monetite, of predefined structured porosity and reabsorbable, and method of synthesis capable of producing said material and applications thereof. These matrices constitute a perfect base for cell colonisation and proliferation permitting application thereof in tissue engineering and osseous regeneration by virtue of their advantageous properties of biocompatibility, reabsorption, osteoinduction, revascularisation, etc.

Classes IPC  ?

  • C01B 25/32 - Phosphates de magnésium, de calcium, de strontium ou de baryum
  • A61L 27/12 - Matériaux contenant du phosphore, p. ex. apatite
  • A61F 2/02 - Prothèses implantables dans le corps
  • A61F 2/28 - Os

27.

THREE-DIMENSIONAL MATRICES OF STRUCTURED POROUS MONETITE FOR TISSUE ENGINEERING AND BONE REGENERATION, AND METHOD OF PREPARATION THEREOF

      
Numéro de document 02729920
Statut Délivré - en vigueur
Date de dépôt 2009-07-08
Date de disponibilité au public 2010-01-14
Date d'octroi 2013-11-19
Propriétaire HISTOCELL, S.L. (Espagne)
Inventeur(s)
  • Font Perez, Julio
  • Castro Feo, Maria Begona
  • Del Olmo Basterrechea, Maite
  • Garcia Vazquez, Maria Dolores
  • Rubio Retama, Jorge
  • Lopez Cabarcos, Enrique
  • Rueda Rodriguez, Carmen
  • Tamimi Marino, Faleh
  • Hamdan Ali Alkhraisat, Mohammad

Abrégé



The present invention is comprised within tissue
engineering and, specifically, within bone regeneration. The
invention relates to a porous three-dimensional matrix of
monetite which is biocompatible, has structured porosity and
is predefined and reabsorbable, as well as to the method of
synthesis capable of producing said material and the
applications thereof. These matrices are a perfect base for
cell colonization and proliferation, allowing the application
thereof in tissue engineering and bone regeneration as a
result of their advantageous properties of biocompatibility,
reabsorption, osteoinduction, revascularization, etc.

Classes IPC  ?

  • A61F 2/02 - Prothèses implantables dans le corps
  • A61F 2/28 - Os
  • A61L 27/12 - Matériaux contenant du phosphore, p. ex. apatite
  • C01B 25/32 - Phosphates de magnésium, de calcium, de strontium ou de baryum

28.

THREE-DIMENSIONAL MATRICES OF STRUCTURED POROUS MONETITE FOR TISSUE ENGINEERING AND OSSEOUS REGENERATION, AND METHOD FOR THE PREPARATION THEREOF

      
Numéro d'application ES2008000482
Numéro de publication 2010/004057
Statut Délivré - en vigueur
Date de dépôt 2008-07-08
Date de publication 2010-01-14
Propriétaire HISTOCELL, S.L (Espagne)
Inventeur(s)
  • Font Perez, Julio
  • Castro Feo, Maria, Begoña
  • Garcia Vazquez, Maria, Dolores
  • Olmo Basterrechea, Maite Del
  • Rubio Retama, Jorge
  • Lopez Cabarcos, Enrique
  • Rueda Rodriguez, Carmen
  • Tamimi Mariño, Faleh
  • Ali Alkhraisat, Mohammad, Hamdan

Abrégé

The present invention is in the field of tissue engineering and, specifically, that of osseous regeneration. The invention relates to a porous three-dimensional matrix of biocompatible monetite, of defined porosity and biodegradable, and the method of synthesis capable of producing said material and applications thereof. These matrices constitute a perfect base for cell colonisation and proliferation permitting application thereof in tissue engineering and osseous regeneration by virtue of their advantageous properties of biocompatibility, reabsorption, osteoinduction, revascularisation, etc.

Classes IPC  ?

  • C01B 25/32 - Phosphates de magnésium, de calcium, de strontium ou de baryum
  • A61L 27/12 - Matériaux contenant du phosphore, p. ex. apatite
  • A61F 2/02 - Prothèses implantables dans le corps
  • A61F 2/28 - Os